Novo Integrated Sciences (NVOS) has provided an announcement.
Novo Integrated Sciences, Inc. has announced they are set to receive approximately $78 million in gross funding from a Standby Letter of Credit (SBLC) facilitated by HSBC. The funds are expected by June 14, 2024, and will be used to finalize the acquisition of the Ophir Collection, granting the company complete ownership. This financial milestone is part of a monetization program the company entered into and is significant for their expansion and asset portfolio growth.
For a thorough assessment of NVOS stock, go to TipRanks’ Stock Analysis page.
